Answers are grounded in this paper and cite their sources.
Treatment-Free Survival in Advanced Renal Cell Carcinoma Trials Evaluating Immuno-Oncology-VEGF TKI Combinations: Sunitinib Group
No takes yet. Share an insight, caveat, or question.
Chang et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: